Allied Market Research published a report, titled, “Cardiovascular Prosthetic Devices Market by Type (Cardiac Prosthetic Devices, Vascular Prosthetic Devices), by End User (Hospitals, Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031“According to the report, the global cardiovascular prosthetic devices industry was valued at $26.93 billion in 2021 and is estimated to generate $61.46 billion by 2031, witnessing a CAGR of 8.6% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chain, regional landscape, and competitive scenario.
Access Sample Data & Findings:
https://www.alliedmarketresearch.com/request-sample/1618
Drivers, Restraints, and Opportunities
The surge in prevalence cardiac diseases, an increase in the number of clinics equipped with advanced technology, a rise in the number of product launches and product approvals for cardiovascular prosthetic devices, a rise in the geriatric population, a rise in disposable income among the population of developing nations, and the growing awareness regarding treatment availability of cardiac diseases drive the cardiovascular prosthetic devices market. However, the high cost of cardiovascular prosthetic devices and cardiovascular surgeries and risk of complications associated with the implantation of cardiovascular prosthetic devices are likely to hinder the market growth during the forecast period. On the other hand, the rise in expenditure by government to develop healthcare infrastructure, the increase in R&D activities in the medical device sector, and an increase in the prevalence of hypertension and obesity will present new growth opportunities for the global market in the coming years.
Growth of the global cardiovascular prosthetic devices market is majorly driven by rise in the number of cardiovascular surgeries, increase in the prevalence of cardiovascular disorders, increase in number of cardiovascular prosthetic devices industry and rise in number of product launch and product approvals. Rise in the number of populations suffering from cardiovascular diseases increases the number of cardiac surgeries. This factor is anticipated to drive the application of cardiovascular prosthetic devices and boosts the cardiovascular prosthetic devices market growth. Cardiovascular prosthetic devices are artificial implants used to help support the heart and its functions. They may be used to replace damaged heart valves, help divert blood flow, or assist with cardiac pacing and other functions.
The cardiac prosthetic devices segment to dominate the market during the forecast period
Based on type, the cardiac prosthetic devices segment contributed to the largest share of over half of the global cardiovascular prosthetic devices market in 2021 and is expected to maintain its dominance during the forecast period. This is owing to a rise in the number of key players who manufacture cardiac prosthetic devices and an increase in the number of product launches and product approvals for cardiac prosthetic devices. However, the vascular prosthetic devices segment is projected to witness the fastest CAGR of 9.0% from 2022 to 2031. This is due to an increase in the number of product approvals for vascular prosthetic devices such as stent in Asia-Pacific.
The hospitals segment to grab the lion’s share during the forecast period
Based on end user, the hospitals segment grabbed the highest share of nearly two-thirds of the cardiovascular prosthetic devices market in 2021 and is expected to dominate the market in 2031. The same segment would witness the fastest CAGR of 8.9% from 2022 to 2031. This is owing to a rise in the number of hospitals and an increase in the number of cardiac surgeries performed globally.
North America to achieve the largest revenue by 2031
Based on region, the market in North America was the largest in 2021, accounting for more than one-third of the global cardiovascular prosthetic devices market and is likely to maintain its dominance during the forecast timeframe. This is owing to a rise in the number of product launches and product approvals, an increase in the number of key players who manufacture cardiovascular prosthetic devices, an increase in number of valve replacement surgeries, and the growing number of developed healthcare infrastructure in the region. However, the market in Asia-Pacific is likely to show the fastest CAGR of 9.4% during the forecast period. This is owing to the rise in expenditure by government organizations to develop the healthcare sector, an increase in the prevalence of cardiac diseases, and a rise in the geriatric population in the region.
Leading Market Players
- B Braun Melsungen AG
- Boston Scientific Corporation
- Artivion Inc.
- Meril Life Sciences Pvt. Ltd.
- Biotronic
- Edwards Lifesciences
- Medtronic PLC
- Johnson and Johnson
- W. L. Gore & Associates Inc.
- Abbott Laboratories
★ See What’s Inside This Report @
https://www.alliedmarketresearch.com/purchase-enquiry/1618
The report analyzes these key players of the global cardiovascular prosthetic devices market. These players have adopted various strategies such as expansion, new product launches, partnerships, and others to increase their market penetration and strengthen their position in the industry. The report is helpful in determining the business performance, operating segments, product portfolio, and developments by every market player.
About Us:
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides end-to-end solutions along with information, education, advocacy, and networking resources to SMEs and early-stage start-ups to bring excellence to their processes. In addition, we offer a nurturing environment required to develop and grow businesses, including business planning; virtual support; market intelligence; acquiring resources; and getting direct access to finance, suppliers, and other experts to boost the growth of businesses and entrepreneurs.
Our bundled and hassle-free business support systems are customized to meet the needs of SME consultants and industry leaders. Moreover, our large network of skilled consultants and experts help start-ups get the business on a roll.
Contact:
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
